Amylyx Pharmaceuticals
AMLX
AMLX
143 hedge funds and large institutions have $141M invested in Amylyx Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 48 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
58% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 60
85% less capital invested
Capital invested by funds: $929M → $141M (-$788M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Holders
143
Holding in Top 10
–
Calls
$20.5M
Puts
$10.6M
Top Buyers
| 1 | +$4.79M | |
| 2 | +$4.26M | |
| 3 | +$3.94M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$3.27M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.86M |
Top Sellers
| 1 | -$43.6M | |
| 2 | -$36.8M | |
| 3 | -$16.4M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$16.2M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$15.6M |